|
Volumn 77, Issue 3-4, 2000, Pages 505-511
|
Pathogenesis and therapeutic aspects of Crohn's disease
|
Author keywords
Crohn's disease; Johne's disease; M.a. paratuberculosis; Pathogenesis; Therapy
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIMYCOBACTERIAL AGENT;
AZATHIOPRINE;
AZITHROMYCIN;
BUDESONIDE;
CIPRAFLOXACIN;
CLARITHROMYCIN;
CLOFAZIMINE;
CORTICOSTEROID;
CYCLOSPORIN;
ETHAMBUTOL;
IMMUNOSUPPRESSIVE AGENT;
MERCAPTOPURINE;
MESALAZINE;
METHOTREXATE;
METRONIDAZOLE;
PREDNISOLONE;
QUINOLONE;
RIFABUTIN;
TUMOR NECROSIS FACTOR;
UNCLASSIFIED DRUG;
ARTICLE;
CIGARETTE SMOKING;
CLINICAL FEATURE;
CROHN DISEASE;
DISEASE COURSE;
DOSE RESPONSE;
ENVIRONMENTAL FACTOR;
HUMAN;
IMMUNE SYSTEM;
IMMUNOSUPPRESSIVE TREATMENT;
KNOCKOUT MOUSE;
MYCOBACTERIUM AVIUM;
PARATUBERCULOSIS;
PATHOGENESIS;
POLYMERASE CHAIN REACTION;
RECURRENT DISEASE;
RISK FACTOR;
TREATMENT OUTCOME;
ANTI-BACTERIAL AGENTS;
ANTI-INFECTIVE AGENTS;
CROHN DISEASE;
HUMANS;
MESALAMINE;
MYCOBACTERIUM PARATUBERCULOSIS;
|
EID: 0034694994
PISSN: 03781135
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-1135(00)00335-7 Document Type: Article |
Times cited : (22)
|
References (11)
|